{
    "title": "Pardes expects to start larger trial of COVID-19 antiviral pill by mid-year",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10511163/Pardes-expects-start-larger-trial-COVID-19-antiviral-pill-mid-year.html",
    "date": "2022-02-14",
    "keywords": [
        "drug",
        "trial",
        "pill",
        "risk",
        "monday",
        "midtolatestage",
        "midyear",
        "earlystage",
        "intake",
        "pbi0451",
        "activity",
        "sarscov2",
        "mild",
        "severity",
        "intervention",
        "company",
        "protease",
        "inhibitor",
        "coronavirus",
        "class",
        "medicine",
        "combination",
        "ritonavir",
        "nirmatrelvir",
        "hospitalization",
        "death",
        "covid19",
        "illness",
        "standalone",
        "treatment",
        "booster",
        "medication",
        "reporting",
        "roy",
        "bengaluru",
        "editing",
        "syamnath"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}